6.10 caner genes Flashcards
oncogene activation by normal expression of a protein with altered function
ras, abl
oncogene activation by overexpression of a normal protein
myc
overexpression can come from
amplification, translocation next to active promoter, insertion of viral promoter
Chronic myelogenous leukemia translocation
translocation of abl gene from chromosome 9 to chormosome 22, sitting right next to the BCR locus –> under this promoter the tyrosine kinase encoded by abl is overexpressed –> chronic myelogenous leukemia
gleevec
specific tyrosine kinase inhibitor that is encoded by abl, since specific to the cancer cells no side effects
burkitts lymphoma mutation
translocation of myc gene from chromosome 8 to chromosome 14, sidding beside the Ig gene
amplifcation of N-myc
n-myc produces double minutes, and amplification can turn cover a large region of the chromosome that can be morphologically picked up
what can you add for membranes to fuse together
propylene glycol - used to fuse immortal cell and specific bcell to make monoclonal antibody
what phenotype do normal and malignant fused cells give you
normal phenotype - something on the normal chromosome suppresses the malignant phenotype bc if that chromosome is kicked out you’ll see the malignant phenotype
Retinoblastoma inherited form
multiple, deletions in all cells
Retinoblastoma spontaneous form
single, deletions only in tumor
Rb inheritance
one allele inactivated at birth, 2nd inactivated by somatic event
Rb function
phosphorylation regulates activity –turns it off, when unphosphorylated the Active Rb gene sequester factors necessary for entering the cell cycle – tumor suppressors
Viral proteins and Rb
viral proteins interfere with Rb gene
hypophosphorylated Rb
binds E2F transcription factors, and that complex binds DNA preventing transcription
Rb is released from E2F when
CDK4 and 6 hyperphosphorylate Rb, releasing E2F, allowing several genes to be transcribed
If Rb is absent or not functional
all the genes normally inhibited by E2F will be constitutively expressed
E2F/DP1/Rb complex inhibits transcription by
recruiting histone deacetylase, that makes chromatin more compact — when the complex is released, histone deacetylase is released allowing for the transcription of genes
Rb can by phosphorylated by
CDK4-cylinD or CDK2-cyclinE
some genes under the control of E2F/DP1/Rb complex
Cyclin A, E, CDK1
loss of Rb gene
knock out mice do not survive and undergo apoptosis in several organs, No Rb leads to apoptosis in many cells but not in retinoblasts
mutations equivalent to losing Rb gene
mutation sin cyclinD, CDk4, CDK6, p16
several other pathways fo growth converge at the Rb gene product such as
TGF beta, transforming proteins of oncogenic viruses binding hypophosphorylated Rb, p53
TGFbeta inhibits cell proliferation by
upregulating p27 and p15 (CDK inhibitors) –> defects give rise to cancer
p53 works by
upregulating CDK inhibitor p21, and inducing apoptosis in cells genetically damaged if repair does not occur
most common mutation found in 50% of human tumors
p53
p53 is activated by
hypoxia, DNA damage
p53 binds DNA and transcriptionally upregulates
p21 (G1 arrest), GADD45 (DNA repair) and bax (apoptosis)
Li-Fraumeni Syndrome
inherited one mutant allele of p53, 25fold increased incidence of malignant tumors by the age of 50
how is Li-Fraumeni syndrome different from Rb mutations
LF patients have a large variety of tumors, develop tumors at a young age, and have multiple primaries
How does hypoxia selecto for mutated p53
hypoxia (along with chemo and radiation) activates p53, and the cells die, so in areas of hypoxia where the cell survives, we know that that cell having a mutated p53 is selected bc it did not die
p53 and chemotherapy/irradiation
if p53 negative, chemo cannot induce apoptosis so this means resistance to therapy
protein similar to p53
p73
BRCA 1 and 2 breast cancer rates
80% of familial and 3% or sporadic; also associated with ovairian cancer